The Need for Critical Examination of Disparities in Immunotherapy and Targeted Therapy Use Among Patients With Cancer

JAMA Oncol. 2021 Aug 1;7(8):1115-1116. doi: 10.1001/jamaoncol.2021.1322.

Authors

Sepideh Ashrafzadeh¹, Maryam M Asgari^{1

2}, Alan C Geller³

Affiliations

¹ Department of Population Medicine, Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts.
² Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
³ Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

PMID: 34042941
DOI: 10.1001/jamaoncol.2021.1322

No abstract available

MeSH terms

Humans
Immunotherapy*
Molecular Targeted Therapy
Neoplasms* / therapy